1. Home
  2. INDP vs FMST Comparison

INDP vs FMST Comparison

Compare INDP & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • FMST
  • Stock Information
  • Founded
  • INDP 2000
  • FMST 2005
  • Country
  • INDP United States
  • FMST Canada
  • Employees
  • INDP N/A
  • FMST N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • FMST Other Metals and Minerals
  • Sector
  • INDP Health Care
  • FMST Basic Materials
  • Exchange
  • INDP Nasdaq
  • FMST Nasdaq
  • Market Cap
  • INDP 10.2M
  • FMST 15.8M
  • IPO Year
  • INDP N/A
  • FMST N/A
  • Fundamental
  • Price
  • INDP $0.94
  • FMST $1.60
  • Analyst Decision
  • INDP Strong Buy
  • FMST
  • Analyst Count
  • INDP 2
  • FMST 0
  • Target Price
  • INDP $8.50
  • FMST N/A
  • AVG Volume (30 Days)
  • INDP 25.7K
  • FMST 34.3K
  • Earning Date
  • INDP 11-12-2024
  • FMST 01-01-0001
  • Dividend Yield
  • INDP N/A
  • FMST N/A
  • EPS Growth
  • INDP N/A
  • FMST N/A
  • EPS
  • INDP N/A
  • FMST N/A
  • Revenue
  • INDP N/A
  • FMST N/A
  • Revenue This Year
  • INDP N/A
  • FMST N/A
  • Revenue Next Year
  • INDP N/A
  • FMST N/A
  • P/E Ratio
  • INDP N/A
  • FMST N/A
  • Revenue Growth
  • INDP N/A
  • FMST N/A
  • 52 Week Low
  • INDP $0.84
  • FMST $1.32
  • 52 Week High
  • INDP $3.10
  • FMST $3.50
  • Technical
  • Relative Strength Index (RSI)
  • INDP 40.51
  • FMST 46.69
  • Support Level
  • INDP $0.94
  • FMST $1.43
  • Resistance Level
  • INDP $1.01
  • FMST $1.77
  • Average True Range (ATR)
  • INDP 0.06
  • FMST 0.20
  • MACD
  • INDP 0.00
  • FMST 0.05
  • Stochastic Oscillator
  • INDP 28.24
  • FMST 61.76

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About FMST Foremost Lithium Resource & Technology Ltd. Common stock

Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with significant historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec.

Share on Social Networks: